Our team

Richard Hall

Operational Director

Richard Hall

Operational Director

Deborah Morris-Rosendahl

Scientific Director

Deborah Morris-Rosendahl

Scientific Director

Sean Whittaker

Medical Director

Sean Whittaker

Medical Director

David McKinnon

Data & Informatics Programme Manager

David McKinnon

Data & Informatics Programme Manager

Robin Ireland

Haematological Malignancy Medical Lead

Robin Ireland

Haematological Malignancy Medical Lead

Nirupa Murugaesu

Cancer Genomic Clinical Lead

Nirupa Murugaesu

Cancer Genomic Clinical Lead

Deborah Ruddy

Rare Disease Medical Lead

Deborah Ruddy

Rare Disease Medical Lead

Debashis Sarker

Cancer Genomic Clinical Lead

Debashis Sarker

Cancer Genomic Clinical Lead

David Brawand

Bioinformatics Lead

David Brawand

Bioinformatics Lead

Jayson Wang

Pathology Lead

Jayson Wang

Pathology Lead

Nicholas Lea

Lead Scientist for Haematological Malignancy

Nicholas Lea

Lead Scientist for Haematological Malignancy

Mikel Valganon

Lead Scientist for Cancer Genomics

Mikel Valganon

Lead Scientist for Cancer Genomics

Michael Yau

Lead Scientist for Rare Disease Genomics

Michael Yau

Lead Scientist for Rare Disease Genomics

Kelly Kohut

Clinical Education and Training Lead

Kelly Kohut

Education and Training Lead

Gail Norbury

Commissioning and Governance Lead

Gail Norbury

Commissioning and Governance Lead

Jeremy Skinner

Quality Manager

Jeremy Skinner

Quality Manager

Olaf Hartberg

General Manager

Olaf Hartberg

General Manager

Rebecca Jebaratnam

Programme Manager

Rebecca Jebaratnam

Programme Manager

Richard Rider

Programme Manager

Richard Rider

Programme Manager
With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
 
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.

Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
 
From April 2019 the interactive test ordering tool will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to directly order tests online.